Phase II study of ifosfamide in childhoo
✍
Chastagner, Pascal ;Sommelet-Olive, Danièle ;Kalifa, Chantal ;Brunat-Mentigny, M
📂
Article
📅
1993
🏛
John Wiley and Sons
🌐
English
⚖ 482 KB
## Abstract Forty‐two evaluable pediatric patients with a variety of recurrent primary brain tumors participated in a phase II ifosfamide trial. Their mean age was 10 years. All patients were treated with ifosfamide, 3 g/m^2^/day for 2 days every 2 weeks. Response was assessed on clinical and radio